For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 87 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Finkel ML.  2019.  A call for action: integrating climate change into the medical school curriculum.. Perspect Med Educ.
Rosenblatt R, Cohen-Mekelburg S, Shen N, Tafesh Z, Lucero C, Kumar S, Fortune B, Liu SYan, Brown R, Jesudian A.  2019.  Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.. Am J Gastroenterol. 114(9):1488-1495.
Edwards DJ, Cortes M, Rykman-Peltz A, Chang J, Elder J, Thickbroom G, Mariman JJ, Gerber LM, Oromendia C, Krebs HI et al..  2019.  Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS.. Restor Neurol Neurosci. 37(2):167-180.
Gordhandas S, Kahn RM, Gamble C, Talukdar N, Maddy B, Nelson BBaltich, Askin G, Christos PJ, Holcomb K, Caputo TA et al..  2020.  Clinicopathologic features of endometrial cancer with mismatch repair deficiency.. Ecancermedicalscience. 14:1061.
Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al..  2020.  CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.
Flory JH, Small DS, Cassano PA, Brillon DJ, Mushlin AI, Hennessy S.  2014.  Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin.. J Comp Eff Res. 3(1):29-39.
Burke LG, Khullar D, Zheng J, Frakt AB, E Orav J, Jha AK.  2019.  Comparison of Costs of Care for Medicare Patients Hospitalized in Teaching and Nonteaching Hospitals.. JAMA Netw Open. 2(6):e195229.
Hays J, Finkel ML, Depledge M, Law A, Shonkoff SBC.  2015.  Considerations for the development of shale gas in the United Kingdom.. Sci Total Environ. 512-513:36-42.
Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al..  2019.  Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.
Schackman BR, Jeng PJ, Flash MJE, Mejia M, Oksuzyan S, Scott JA, Freedberg KA, Kulkarni SP, Garland WH.  2019.  Cost of an HIV Medical Care Coordination Program in Los Angeles County.. J Acquir Immune Defic Syndr. 81(1):e15-e17.
Schackman BR, Jeng PJ, Flash MJE, Mejia M, Oksuzyan S, Scott JA, Freedberg KA, Kulkarni SP, Garland WH.  2019.  Cost of an HIV Medical Care Coordination Program in Los Angeles County.. J Acquir Immune Defic Syndr. 81(1):e15-e17.
Behrends CN, Eggman AA, Gutkind S, Bresnahan MP, Fluegge K, Laraque F, Litwin AH, Meissner P, Shukla SJ, Perumalswami PV et al..  2019.  A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.. J Public Health Manag Pract. 25(3):253-261.
Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Yazdi GEftekhari, Stein MD, Freedberg KA, Linas BP.  2019.  Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.. Int J Drug Policy.
Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Yazdi GEftekhari, Stein MD, Freedberg KA, Linas BP.  2019.  Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids.. Int J Drug Policy.